title: Anatumomab mafenatox
text: # Anatumomab mafenatox
  
  Anatumomab mafenatox is a mouse monoclonal antibody studied for the treatment non-small cell lung cancer, which acts as a tumor-targeted superantigen.
  
  It is a fusion protein of a human tumor-associated 5T4 antigen monoclonal IgG1 Fab fragment with an enterotoxin ('mafenatox') of Staphylococcus aureus.
  
  Development was abandoned in 2005.
  
  